Silvi Zakiyatul Ilmiyah

Silvi Zakiyatul Ilmiyah

Auto-generated profile, based on publicly available information

Silvi Zakiyatul Ilmiyah

Doctoral Program in Medical Sciences, Faculty of Medicine, Universitas Brawijaya, Malang, Indonesia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
SPSofy Permana
Sofy Permana
ENElsafira A. Nabilahasna
Elsafira A. Nabilahasna
FMFairuz A. Meilany
Fairuz A. Meilany
SISilvi Zakiyatul Ilmiyah
Silvi Zakiyatul Ilmiyah
EWEdwin Widodo
Edwin Widodo
AEAgustina T. Endharti
Agustina T. Endharti
Context: Colorectal cancer (CRC) is a major global health concern as innovative therapeutic strategies to enhance treatment outcomes. This study investigates the therapeutic potential of the ethanol extract derived from Volvariella volvacea in combination with cetuximab for CRC. Aims: To evaluate the inhibition of topoisomerase II alpha (TOP2A) and include the peroxisome proliferator-activated receptor gamma (PPARγ), a key regulator of cell growth and differentiation. Methods: The method used computational modeling and molecular docking to assess the binding affinities and interactions between the bioactive components, cetuximab, TOP2A, and PPARγ. In vitro experiments were conducted using CRC cell lines. Cells were treated with cetuximab alone or in combination with V. volvacea extract. Cell viability and immunofluorescence were conducted to evaluate the effect of combination therapy on TOP2A and PPARγ. Results: The results unveiled compelling binding interactions, suggesting the potential for dual targeting of TOP2A and PPARγ. The results demonstrated a reduction in cell viability, downregulation of TOP2A, and modulation of PPARγ. These findings indicate the potential of V. volvacea extract as an adjuvant therapy to cetuximab in CRC. Targeting both TOP2A and PPARγ enhances the efficacy of CRC treatment. Conclusions: Moreover, it highlights the importance of harnessing natural compounds and molecular insights to develop innovative combinatorial therapies for complex diseases like CRC.

24 April 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
YKYoshiyuki Kawamoto
Yoshiyuki Kawamoto
YFYui Furuhashi
Yui Furuhashi
SISilvi Zakiyatul Ilmiyah
Silvi Zakiyatul Ilmiyah
SYSeiji Yamaguchi
Seiji Yamaguchi
NNNozomi Nishimura
Nozomi Nishimura
KTKozue Takeda
Kozue Takeda
Despite extensive development of anticancer agents, there remains a critical need for therapeutics with novel mechanisms of action. This study reports the potent anticancer activity and mechanistic analysis of highly water-soluble dopa-melanin (DM) prepared through a unique synthetic process. DM exhibits distinctive structural and chemical properties that contribute to its exceptional aqueous solubility (≥50 mg/ml) and may underlie its enhanced biological activity. DM reduced cell viability in multiple cancer cell lines. Using HeLa cells as a representative model, DM suppressed cell migration and three-dimensional growth. Fractionation revealed that activity was associated with polymers larger than 30 kDa, suggesting a critical role for high-molecular-weight species. Mechanistic studies showed that DM induced S/G2/M arrest followed by cell death with minimal apoptotic body formation. DM rapidly decreased cyclin D1 and D3 protein and mRNA levels. A pan-caspase inhibitor significantly suppressed DM's inhibitory effect on cell viability but did not prevent cyclin D degradation. Cyclin D degradation was mediated through calcium-dependent calpain activation triggered by endoplasmic reticulum Ca2+ release via IP3 receptors, and inhibition of this pathway attenuated DM's activity. In a mouse syngeneic tumor model, oral administration of DM significantly inhibited tumor growth without apparent toxicity. These results demonstrate that both caspase-dependent apoptosis and a caspase-independent cyclin D degradation pathway contribute to DM-induced cell death. Its high solubility, oral efficacy, and unique mechanism of action make DM a promising candidate for therapeutic development.

1 April 2025 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
SISilvi Zakiyatul Ilmiyah
Silvi Zakiyatul Ilmiyah
SPSofy Permana
Sofy Permana
EWEdwin Widodo
Edwin Widodo
ENEviana Norahmawati
Eviana Norahmawati
Happy Kurnia PermatasariHappy Kurnia Permatasari
Happy Kurnia Permatasari
AEAgustina Tri Endharti
Agustina Tri Endharti
Context: Breast cancer is characterized by the abnormal growth of cells in the ducts and lobules of the breast. Numerous therapeutic targets for breast cancer are currently under investigation, one of which is matrix metalloproteinase-2 (MMP-2), a heterodimeric protein highly expressed in circulating tumor cells from patients with pancreatic carcinoma, positioning it as a potential target for breast cancer therapy. Anredera cordifolia is a plant known for its medicinal properties with anti-cancer effects, particularly in breast cancer. Aims: To determine the potential of compounds derived from A. cordifolia leaves as drug candidates, specifically focusing on their binding affinity to inhibit the metastasis pathway of MMP-2 protein in breast cancer. Methods: A. cordifolia leaf extraction and LC-MS analysis compound screening, ligand preparation, ADMET analysis, protein pathway network interaction analysis, molecular docking, and molecular dynamics simulations were performed. Results: LC-MS results showed six compounds in A. cordifolia that exhibited the highest mass spectrum values. These were vitexin, saponin, betalain, bethanidine, terpenoid, and ursolic acid. The six compounds were docked with the MMP-2 protein. The highest binding affinities were observed for saponin (-10 kcal/mol), ursolic acid (-9.1 kcal/mol), and vitexin (-8.8 kcal/mol). The molecular dynamics simulations demonstrated that all compounds exhibited stable interactions, with average RMSD values ranging from 1-3 Å. Conclusions: The binding affinity values, binding site similarity of some amino acid residues with the control, and molecular dynamics results for the ligand from A. cordifolia showed stable binding to the MMP-2 protein with a low level of fluctuation.

1 May 2024 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
SISilvi Z. Ilmiyah
Silvi Z. Ilmiyah
SFSharida Fakurazi
Sharida Fakurazi
AEAgustina T. Endharti
Agustina T. Endharti
SPSofy Permana
Sofy Permana
Context: Coronavirus disease 2019 (COVID-19), a highly contagious viral disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide pandemic. Selenium derived from the plants of the Brassicaceae family plays an important role in several biological functions, often as an antioxidant or antiviral. In particular, selenium can be used as an adjuvant in the treatment of various viral infections. Aims: To determine the potential drug, as well as the affinity and the bond energy associated with chemical interaction bonds between the complex selenium compounds from Brassicaceae as inhibitors of the SARS-CoV-2 spike protein and MAP4 through the use of in silico studies. Methods: The methods used in this study consisted of receptor and ligand data collection, ADMET analysis, molecular docking, and molecular dynamics. Results: The results of this study indicate that the selenium complex compounds have the potential to be used as a spike inhibitor drug for SARS-CoV-2, as they have passed the Lipinski test and showed promise in the pharmacokinetic analysis. The results of the bond docking show that several complex selenium compounds, such as ethaselen, selenomethionine, and selenocystine, have stronger binding affinity values than the controls. This is compared to the control MAP4, which yielded binding affinities of -6.1 kcal/mol and spike protein -7 kcal/mol, respectively. Controlled bisoxatin and estramustine are drugs with mechanisms targeted to MAP4 and spike protein, which are the usual standards used. Conclusions: The similarity of sites, the binding of several amino acid residues dominated by hydrogen bonds, and the result of molecular dynamic results for the selenium compound derived from Brassicaceae showed a stable bond to the spike protein and MAP4 with low fluctuation levels.

1 March 2025 in Journal of Pharmacy & Pharmacognosy Research
Verified
Journal Article
Open access
SISilvi Zakiyatul Ilmiyah
Silvi Zakiyatul Ilmiyah
AMAges Mamamia
Ages Mamamia
SPSofy Permana
Sofy Permana
EWEdwin Widodo
Edwin Widodo
ENEviana Norahmawati
Eviana Norahmawati
AEAgustina Tri Endharti
Agustina Tri Endharti
Context: Cancer is one of the causes of death throughout the world. There are around 9.6 million deaths from cancer every year throughout the world, with 70% of cancer deaths occurring in developing countries in the world. Natural species like Anredera cordifolia is the old-world diamond flower. It is historically important in traditional Chinese medicine. It's commonly found in Indonesia, notably Java, and has gained attention for its potential anticancer effects. Aims: To evaluate the existing research on the bioactive compounds of A. cordifolia leaves and their anticancer potentials. Methods: The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), using databases like PubMed, ResearchGate, ScienceDirect, and Google Scholar via Rayyan.ai. Sixteen included primary studies were analyzed descriptively. Results: Results revealed A. cordifolia active compounds acting against anticancer. Activities included anti-proliferation (induce Cav-1, reduce glycolysis pathway, p38, MAPK, and ERK 1/2), apoptosis, antioxidant effects, cytotoxicity, inhibiting tumor progression genes, reducing metastatic genes (MMP-9), and enhancing pro-apoptotic genes (BAX, P53, caspase-3, caspase-8, caspase-9, cleaved PARP). Conclusions: According to the mechanisms studied, A. cordifolia extract could be showed promise as a potential anti-cancer agent.

1 January 2026 in Brazilian Journal of Biology
Verified
Journal Article
Open access
AKA. T. N. Krisnaningsih
A. T. N. Krisnaningsih
Premy RahayuPremy Rahayu
Premy Rahayu
DHD. P. P. Hadiani
D. P. P. Hadiani
SIS. Z. Ilmiyah
S. Z. Ilmiyah
AHA. F. Husen
A. F. Husen
NSN. E. Saputri
N. E. Saputri
Apple peel (Malus sp.), a by-product of fruit processing, is rich in phenolic compounds, particularly quercetin, as well as other flavonoids and dietary fiber. This study integrated conventional maceration with Microwave-Assisted Extraction (MAE) to obtain phenolic- and flavonoid-rich apple peel extracts and to explore their potential interaction with major dairy proteins through in silico docking. Apple peel powders were first macerated and then subjected to MAE at irradiation times (3, 6, 9, and 12 minutes). The extracts were assessed for antioxidant activity (DPPH), total phenolic content (TPC), and total flavonoid content (TFC), with all experiments performed in triplicate and analyzed using one-way ANOVA followed by an appropriate post hoc test. Prolonged MAE treatment enhanced antioxidant activity (93.85–95.09%), phenolic content (13.52–14.73 mg GAE/g), and flavonoid content (23.76–29.62 ppm). Molecular docking indicated that quercetin showed comparable predicted binding affinity toward both milk proteins, with binding energy values of −6.7 kcal/mol for β-lactoglobulin and −6.9 kcal/mol for α-lactalbumin. These findings suggest that apple peel extract obtained through integrated extraction may have potential for future application in dairy-based functional systems, although formulation and stability studies are still required.